Frustrations With Isotretinoin REMS Evident at FDA Meeting Frustrations With Isotretinoin REMS Evident at FDA Meeting

The FDA advisory panel meeting was held to address proposed changes to the iPLEDGE REMS to minimize burden on patients, prescribers, and pharmacies while maintaining safe use of isotretinoin.MDedge News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news